Cytokine Immunotherapy CD Protein Inhibitors Chemotherapy Tyrosine Kinase Inhibitors Kinase Inhibitors DNA Other BCL Inhibitors Interleukins Epigenetics MDM2/MDMX | Chronic Lymphocytic Leukemia | Acute Myelogenous Leukemia | Myelodysplastic Syndrome | Chronic Myeloid Leukemia | Melanoma |
---|---|---|---|---|---|
zanubrutinib | |||||
CA-4948 | |||||
luspatercept-aamt | |||||
cytarabine/daunorubicin liposomal formulation | |||||
venetoclax + ABBV 075 | |||||
obinutuzumab + GS-9973 | |||||
RG7388 | |||||
VE-821 | |||||
HPB-092 | |||||
ofatumumab | |||||
chlorambucil | |||||
obinutuzumab | |||||
venetoclax | |||||
lenalidomide | |||||
Immunotherapy |